ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 768 filers reported holding ISHARES TR in Q2 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,295,000 | -2.7% | 67,830 | +1.0% | 0.97% | +4.1% |
| Q2 2023 | $8,528,000 | -0.3% | 67,167 | +1.4% | 0.93% | -6.9% |
| Q1 2023 | $8,555,000 | -3.0% | 66,239 | -0.9% | 1.00% | -5.8% |
| Q4 2022 | $8,820,000 | +12.6% | 66,840 | -0.2% | 1.06% | -0.8% |
| Q3 2022 | $7,831,000 | +0.2% | 66,956 | +0.8% | 1.07% | +4.0% |
| Q2 2022 | $7,816,000 | -9.7% | 66,449 | +0.1% | 1.02% | +6.0% |
| Q1 2022 | $8,653,000 | -11.2% | 66,412 | +4.1% | 0.97% | -8.9% |
| Q4 2021 | $9,741,000 | -3.7% | 63,822 | +2.0% | 1.06% | -12.7% |
| Q3 2021 | $10,112,000 | +1.9% | 62,541 | +3.1% | 1.22% | +5.7% |
| Q2 2021 | $9,924,000 | +13.3% | 60,643 | +4.3% | 1.15% | +8.2% |
| Q1 2021 | $8,756,000 | +2.4% | 58,159 | +3.1% | 1.06% | -5.6% |
| Q4 2020 | $8,549,000 | +14.0% | 56,433 | +1.9% | 1.13% | +0.3% |
| Q3 2020 | $7,498,000 | +3.0% | 55,373 | +4.0% | 1.12% | -5.1% |
| Q2 2020 | $7,279,000 | +26.7% | 53,251 | -0.2% | 1.18% | +3.0% |
| Q1 2020 | $5,747,000 | -13.0% | 53,340 | -2.7% | 1.15% | +19.0% |
| Q4 2019 | $6,605,000 | +21.7% | 54,811 | +0.5% | 0.96% | +15.0% |
| Q3 2019 | $5,428,000 | -7.4% | 54,551 | +1.5% | 0.84% | -4.2% |
| Q2 2019 | $5,862,000 | +1.4% | 53,726 | +3.9% | 0.88% | +1.3% |
| Q1 2019 | $5,780,000 | +21.5% | 51,701 | +4.8% | 0.86% | +10.8% |
| Q4 2018 | $4,756,000 | -19.3% | 49,321 | +2.0% | 0.78% | -6.0% |
| Q3 2018 | $5,893,000 | +13.8% | 48,331 | +2.5% | 0.83% | +10.2% |
| Q2 2018 | $5,178,000 | +6.8% | 47,147 | +3.8% | 0.75% | +4.4% |
| Q1 2018 | $4,847,000 | +3.3% | 45,412 | +3.3% | 0.72% | +10.2% |
| Q4 2017 | $4,693,000 | -1.4% | 43,957 | +208.2% | 0.66% | -5.3% |
| Q3 2017 | $4,758,000 | +13.4% | 14,264 | +5.5% | 0.69% | +7.6% |
| Q2 2017 | $4,194,000 | +7.8% | 13,524 | +1.9% | 0.64% | +10.7% |
| Q1 2017 | $3,891,000 | +8.7% | 13,269 | +7.3% | 0.58% | -2.0% |
| Q4 2016 | $3,581,000 | 0.0% | 12,371 | 0.0% | 0.59% | 0.0% |
| Q3 2016 | $3,581,000 | +12.5% | 12,371 | +0.1% | 0.59% | +8.4% |
| Q2 2016 | $3,182,000 | +2.2% | 12,364 | +3.6% | 0.55% | -1.8% |
| Q1 2016 | $3,113,000 | -12.4% | 11,934 | +13.6% | 0.56% | -12.0% |
| Q4 2015 | $3,554,000 | +16.4% | 10,506 | +4.4% | 0.63% | +1.3% |
| Q3 2015 | $3,052,000 | -16.0% | 10,062 | +2.1% | 0.62% | -6.7% |
| Q2 2015 | $3,635,000 | +5.4% | 9,852 | -1.9% | 0.67% | +11.3% |
| Q1 2015 | $3,449,000 | +14.4% | 10,042 | +1.1% | 0.60% | +16.4% |
| Q4 2014 | $3,014,000 | +13.0% | 9,937 | +1.9% | 0.52% | +7.5% |
| Q3 2014 | $2,667,000 | +10.3% | 9,747 | +3.6% | 0.48% | +8.3% |
| Q2 2014 | $2,418,000 | +13.2% | 9,407 | +4.1% | 0.44% | +1.1% |
| Q1 2014 | $2,136,000 | +40.7% | 9,037 | +35.1% | 0.44% | +65.7% |
| Q4 2013 | $1,518,000 | +29.2% | 6,687 | +19.3% | 0.26% | +16.7% |
| Q3 2013 | $1,175,000 | +16.6% | 5,607 | -3.3% | 0.23% | +8.1% |
| Q2 2013 | $1,008,000 | – | 5,797 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |